1 After 1, 2, 3, and 4 wk of tumor growth, dual-modality
imaging was performed 3 d after intravenous injection of (111
2 Magnetic resonance (MR)
imaging was performed a year later to control the progression
3 Follow-up magnetic resonance
imaging was performed after a mean (standard deviation) inter
4 Scheimpflug-based Oculus Pentacam
imaging was performed after DMEK surgery for Fuchs endothelia
5 Imaging was performed after injection of 400 MBq of (99m)Tc-C
6 To better characterize the lesions, multimodal
imaging was performed and included: optic coherence tomograph
7 Cardiac MR
imaging was performed at 1.5 T in 156 healthy volunteers (63%
8 Magnetic resonance
imaging was performed at an academic research neuroimaging ce
9 Imaging was performed at baseline and after 8 and 24 wk of fi
10 Cardiac magnetic resonance
imaging was performed at baseline.
11 Imaging was performed at Columbia University Medical Center f
12 Imaging was performed at rest and during 6-min hypercapnic pl
13 Real-time
imaging was performed at the center of restoration by the OCT
14 Breast MR
imaging was performed before and after treatment.
15 Imaging was performed every 6 to 9 weeks.
16 Directly after administration of 3 MBq/kg of FCH, PET
imaging was performed,
followed by T1- and T2-weighted MR ima
17 Dual-repetition time three-dimensional hybrid-radial UTE
imaging was performed,
followed by the application of postpro
18 PET
imaging was performed for (68)Ga-aquibeprin and the previousl
19 Systematic follow-up MR
imaging was performed for 24 months on average to assess comp
20 Dynamic
imaging was performed for 60 minutes following Mn-PyC3A injec
21 Results MR
imaging was performed for high-risk screening in 240 of the 4
22 Dynamic PET/CT
imaging was performed immediately after injection of (18)F-FD
23 Multimodal retinal
imaging was performed in 11 eyes with acute retinal vascular
24 Imaging was performed in 20 adult patients with asthma by usi
25 MATERIAL/METHODS: Retrospective analysis of
imaging was performed in 33 patients who presented with sympt
26 Imaging was performed in addition to established clinical ima
27 Multimodality
imaging was performed in AR42J xenografts.
28 BOLD MR
imaging was performed in donors before uninephrectomy and in
29 ne and 5 and 10 wk after start of therapy) (18)F-FDG PET/CT
imaging was performed in patients with newly diagnosed OS tre
30 DT
imaging was performed in seven healthy volunteers and three p
31 [(89)Zr]Zr-DFO-daratumumab PET/CT small-animal
imaging was performed in severe combined immunodeficient mice
32 cation has an effect on brain structure, magnetic resonance
imaging was performed in the context of a clinical trial on t
33 hether the intradisulfide modulates cGMP binding, real-time
imaging was performed in vascular smooth muscle cells express
34 Handheld OCT
imaging was performed longitudinally on all patients.
35 METHODS AND Cardiac magnetic resonance
imaging was performed on 358 consecutive genotyped hypertroph
36 (18)F-AV-1451 PET
imaging was performed on 43 subjects (5 young HCs, 23 older H
37 Contrast material-enhanced multiphase MR
imaging was performed on postprocedure days 1 and 30 and ever
38 Open-field fluorescence
imaging was performed preoperatively and during the surgical
39 Before biopsy, full diagnostic contrast-enhanced MR
imaging was performed that included DWIBS (b = 1500 sec/mm(2)
40 PET/CT
imaging was performed to visualize (18)F-FLT biodistribution
41 METHODS AND NFUS
imaging was performed using a specially designed open-irrigat
42 Placental perfusion
imaging was performed using velocity-selective arterial spin
43 Imaging was performed with a 3-T MR imager by using different
44 diabatically prepared chemical exchange-sensitive spin-lock
imaging was performed with a 7.0-T whole-body unit with a tem
45 Functional magnetic resonance (MR)
imaging was performed with a psychomotor vigilance task (sust
46 Clinical, diagnostic 3-T MR
imaging was performed with in-bore guided prostate biopsy, an
47 T1rho-weighted DGE MR
imaging was performed with injection of 100 mL of 20% d-gluco
48 Dosimetry from multi-time-point PET
imaging was performed with OLINDA/EXM.
49 Imaging was performed with spectral-domain optical coherence
50 resonance (MR) imaging (T1-weighted and diffusion-weighted
imaging) was performed with a 3-T MR imager.